Date:30-Apr-2024  Time: 7:04 AM
 
 
        
Salora International Ltd
(Rs. In Crores)
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales Turnover 116.0670.0787.78168.79175.83
Other Income 2.0263.040.870.160.18
Stock Adjustments -1.24-6.32-1.11-6.890.67
Total Income116.84126.7987.54162.06176.68
Raw Materials 111.7565.0283.66155.17162.89
Excise Duty0.000.000.000.000.00
Power & Fuel Cost0.130.210.250.490.51
Other Manufacturing Expenses 0.630.460.421.691.56
Employee Cost 2.353.413.164.225.01
Selling and Administration Expenses 2.212.172.263.094.37
Miscellaneous Expenses 10.3424.216.600.86-3.78
Less: Preoperative Expenditure Capitalised0.000.000.000.000.00
Profit before Interest, Depreciation & Tax-10.5731.31-8.79-3.466.13
Interest & Financial Charges 1.083.156.137.457.43
Profit before Depreciation & Tax-11.6528.16-14.92-10.91-1.30
Depreciation0.200.440.632.001.95
Profit Before Tax-11.8527.73-15.55-12.91-3.25
Tax-2.883.68-4.140.631.63
Profit After Tax-8.9724.05-11.41-13.54-4.88
Adjustment below Net Profit 0.000.000.000.000.00
P & L Balance brought forward-14.10-38.15-26.74-13.20-8.32
Appropriations 0.000.000.000.000.00
P & L Bal. carried down-23.07-14.10-38.15-26.74-13.20
Equity Dividend0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Corporate Dividend Tax0.000.000.000.000.00
Equity Dividend (%)0.000.000.000.000.00
Earning Per Share (Rs.)-10.1827.28-12.95-15.36-5.53
Book Value66.3576.6249.3762.3477.66
Extraordinary Items -7.6736.18-5.49-0.24-0.06
 
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com